The effect of Green green tea consumption on body mass index, lipoprotein, liver enzymes, and liver cancer: An updated systemic review incorporating a meta-analysis

References

• Abe, I., T. Seki, K. Umehara, T. Miyase, H. Noguchi, J. Sakakibara, and T. Ono. 2000. Green tea polyphenols: Novel and potent inhibitors of squalene epoxidase. Biochemical and Biophysical Research Communications 268 (3):767–71. doi: 10.1006/bbrc.2000.2217.
   PubMed Web of Science ®Google Scholar
• Balentine, D. A., S. A. Wiseman, and L. C. Bouwens. 1997. The chemistry of tea flavonoids. Critical Reviews in Food Science and Nutrition 37 (8):693–704. doi: 10.1080/10408399709527797.
   PubMed Web of Science ®Google Scholar
• Batista, GdA. P, et al. 2009. Prospective double-blind crossover study of Camellia sinensis (green tea) in dyslipidemias. Age (Years) 55 (10.1):21.0–71.0.
   Google Scholar
• Bursill, C. A, and P. D. Roach. 2007. A green tea catechin extract upregulates the hepatic low-density lipoprotein receptor in rats. Lipids 42 (7):621–7. doi: 10.1007/s11745-007-3077-x.
   PubMed Web of Science ®Google Scholar
• Bursill, C. A., M. Abbey, and P. D. Roach. 2007. A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and ­upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis 193 (1):86–93. doi: 10.1016/j.atherosclerosis.2006.08.033.
   PubMed Web of Science ®Google Scholar
• Chan, C. C. W., M. W. L. Koo, E. H. Y. Ng, O.-S. Tang, W. S. B. Yeung, and P.-C. Ho. 2006. Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome—a randomized placebo-controlled trial. Journal of the Society for Gynecologic Investigation 13 (1):63–8. doi: 10.1016/j.jsgi.2005.10.006.
   PubMedGoogle Scholar
• Chan, P. T., W. P. Fong, Y. L. Cheung, Y. Huang, W. K. K. Ho, and Z.-Y. Chen. 1999. Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet. The Journal of Nutrition 129 (6):1094–101. doi: 10.1093/jn/129.6.1094.
   PubMed Web of Science ®Google Scholar
• Diepvens, K., E. Kovacs, N. Vogels, and M. Westerterpplantenga. 2006. Metabolic effects of green tea and of phases of weight loss. Physiology & Behavior 87 (1):185–91. doi: 10.1016/j.physbeh.2005.09.013.
   PubMed Web of Science ®Google Scholar
• Endo, A. 1992. The discovery and development of HMG-CoA reductase inhibitors. Journal of Lipid Research 33 (11):1569–82. doi: 10.1016/S0022-2275(20)41379-3.
   PubMed Web of Science ®Google Scholar
• Frank, J., T. W. George, J. K. Lodge, A. M. Rodriguez-Mateos, J. P. E. Spencer, A. M. Minihane, and G. Rimbach. 2009. Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. The Journal of Nutrition 139 (1):58–62. doi: 10.3945/jn.108.096412.
   PubMed Web of Science ®Google Scholar
• Fukino, Y., A. Ikeda, K. Maruyama, N. Aoki, T. Okubo, and H. Iso. 2008. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. European Journal of Clinical Nutrition 62 (8):953–60. doi: 10.1038/sj.ejcn.1602806.
   PubMed Web of Science ®Google Scholar
• Fukuzawa, Y., M. P. Kapoor, K. Yamasaki, T. Okubo, Y. Hotta, and L. R. Juneja. 2014. Effects of green tea catechins on nonalcoholic steatohepatitis (NASH) patients. Journal of Functional Foods 9:48–59. doi: 10.1016/j.jff.2014.04.010.
   Web of Science ®Google Scholar
• Gupta, A., A. Das, K. Majumder, N. Arora, H. G. Mayo, P. P. Singh, M. S. Beg, and S. Singh. 2018. Obesity is independently associated with increased risk of hepatocellular cancer–related mortality. American Journal of Clinical Oncology 41 (9):874–81. doi: 10.1097/COC.0000000000000388.
   PubMed Web of Science ®Google Scholar
• Hayden, J. A., D. A. van der Windt, J. L. Cartwright, P. Côté, and C. Bombardier. 2013. Assessing bias in studies of prognostic factors. Annals of Internal Medicine 158 (4):280–6. doi: 10.7326/0003-4819-158-4-201302190-00009.
   PubMed Web of Science ®Google Scholar
• Higgins, J. P. T., S. G. Thompson, J. J. Deeks, and D. G. Altman. 2003. Measuring inconsistency in meta-analyses. BMJ (Clinical Research ed.) 327 (7414):557–60. doi: 10.1136/bmj.327.7414.557.
   PubMed Web of Science ®Google Scholar
• Hsu, C.-H., T.-H. Tsai, Y.-H. Kao, K.-C. Hwang, T.-Y. Tseng, and P. Chou. 2008. Effect of green tea extract on obese women: A randomized, double-blind, placebo-controlled clinical trial. Clinical Nutrition (Edinburgh, Scotland) 27 (3):363–70. doi: 10.1016/j.clnu.2008.03.007.
   PubMed Web of Science ®Google Scholar
• Hussain, M, and L. Akhtar. 2017. Therapeutic benefits of green tea extract on various parameters in non-alcoholic fatty liver disease patients. Pakistan Journal of Medical Sciences 33 (4):931–6. doi: 10.12669/pjms.334.12571.
   PubMed Web of Science ®Google Scholar
• Imai, K, and K. Nakachi. 1995. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 310 (6981):693–6. doi: 10.1136/bmj.310.6981.693.
   PubMedGoogle Scholar
• Inoue, M., N. Kurahashi, M. Iwasaki, T. Shimazu, Y. Tanaka, M. Mizokami, and S. Tsugane. 2009. Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidemiology, Biomarkers & Prevention 18 (6):1746–53. doi: 10.1158/1055-9965.EPI-08-0923.
   PubMed Web of Science ®Google Scholar
• Jain, K. S., M. K. Kathiravan, R. S. Somani, and C. J. Shishoo. 2007. The biology and chemistry of hyperlipidemia. Bioorganic & Medicinal Chemistry 15 (14):4674–99. doi: 10.1016/j.bmc.2007.04.031.
   PubMed Web of Science ®Google Scholar
• Kafeshani, M., M. H. Entezari, J. Karimian, M. Pourmasoumi, M. R. Maracy, M. R. Amini, and A. Hadi. 2017. A comparative study of the effect of green tea and sour tea on blood pressure and lipid profile in healthy adult men. ARYA Atherosclerosis 13 (3):109–16.
   PubMed Web of Science ®Google Scholar
• Koo, S. I, and S. K. Noh. 2007. Green tea as inhibitor of the intestinal absorption of lipids: Potential mechanism for its lipid-lowering effect. The Journal of Nutritional Biochemistry 18 (3):179–83. doi: 10.1016/j.jnutbio.2006.12.005.
   PubMed Web of Science ®Google Scholar
• Kuriyama, S., T. Shimazu, K. Ohmori, N. Kikuchi, N. Nakaya, Y. Nishino, Y. Tsubono, and I. Tsuji. 2006. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: The Ohsaki study. JAMA 296 (10):1255–65. doi: 10.1001/jama.296.10.1255.
   PubMed Web of Science ®Google Scholar
• Lee, M.-J. 2002. Pharmacokinetics of tea catechins after ingestion of green tea and (−)-epigallocatechin-3-gallate by humans: Formation of different metabolites and individual variability. Cancer Epidemiology and Prevention Biomarkers 11 (10):1025–32.
   PubMed Web of Science ®Google Scholar
• Liberati, A., D. G. Altman, J. Tetzlaff, C. Mulrow, P. C. Gøtzsche, J. P. A. Ioannidis, M. Clarke, P. J. Devereaux, J. Kleijnen, D. Moher, et al. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Journal of Clinical Epidemiology 62 (10):e1–e34. doi: 10.1016/j.jclinepi.2009.06.006.
   PubMed Web of Science ®Google Scholar
• Maki, K. C., M. S. Reeves, M. Farmer, K. Yasunaga, N. Matsuo, Y. Katsuragi, M. Komikado, I. Tokimitsu, D. Wilder, F. Jones, et al. 2009. Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. The Journal of Nutrition 139 (2):264–70. doi: 10.3945/jn.108.098293.
   PubMed Web of Science ®Google Scholar
• Maron, D. J., G. P. Lu, N. S. Cai, Z. G. Wu, Y. H. Li, H. Chen, J. Q. Zhu, X. J. Jin, B. C. Wouters, J. Zhao, et al. 2003. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: A randomized controlled trial. Archives of Internal Medicine 163 (12):1448–53. doi: 10.1001/archinte.163.12.1448.
   PubMed Web of Science ®Google Scholar
• Mazzanti, G., F. Menniti-Ippolito, P. A. Moro, F. Cassetti, R. Raschetti, C. Santuccio, and S. Mastrangelo. 2009. Hepatotoxicity from green tea: A review of the literature and two unpublished cases. European Journal of Clinical Pharmacology 65 (4):331–41. doi: 10.1007/s00228-008-0610-7.
   PubMed Web of Science ®Google Scholar
• Nagano, J., S. Kono, D. L. Preston, and K. Mabuchi. 2001. A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes & Control : CCC 12 (6):501–8.
   PubMed Web of Science ®Google Scholar
• Nagao, T., S. Meguro, T. Hase, K. Otsuka, M. Komikado, I. Tokimitsu, T. Yamamoto, and K. Yamamoto. 2009. A catechin‐rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity (Silver Spring, Md.) 17 (2):310–7. doi: 10.1038/oby.2008.505.
   PubMed Web of Science ®Google Scholar
• Nagao, T., T. Hase, and I. Tokimitsu. 2007. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring, Md.) 15 (6):1473–83. doi: 10.1038/oby.2007.176.
   PubMed Web of Science ®Google Scholar
• Nagao, T., Y. Komine, S. Soga, S. Meguro, T. Hase, Y. Tanaka, and I. Tokimitsu. 2005. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. The American Journal of Clinical Nutrition 81 (1):122–9. doi: 10.1093/ajcn/81.1.122.
   PubMed Web of Science ®Google Scholar
• Nakagawa, K., S. Okuda, and T. Miyazawa. 1997. Dose-dependent incorporation of tea catechins,(-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Bioscience, Biotechnology, and Biochemistry 61 (12):1981–5. doi: 10.1271/bbb.61.1981.
   PubMed Web of Science ®Google Scholar
• Nantz, M. P., C. A. Rowe, J. F. Bukowski, and S. S. Percival. 2009. Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nutrition (Burbank, Los Angeles County, Calif.) 25 (2):147–54. doi: 10.1016/j.nut.2008.07.018.
   PubMed Web of Science ®Google Scholar
• Nechuta, S., X.-O. Shu, H.-L. Li, G. Yang, B.-T. Ji, Y.-B. Xiang, H. Cai, W.-H. Chow, Y.-T. Gao, W. Zheng, et al. 2012. Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai Women’s Health Study. The American Journal of Clinical Nutrition 96 (5):1056–63. doi: 10.3945/ajcn.111.031419.
   PubMed Web of Science ®Google Scholar
• Pezeshki, A., S. Safi, A. Feizi, G. Askari, and F. Karami. 2016. The effect of green tea extract supplementation on liver enzymes in patients with nonalcoholic fatty liver disease. International Journal of Preventive Medicine 7 (1):28. doi: 10.4103/2008-7802.173051.
   PubMedGoogle Scholar
• Princen, H. M., W. van Duyvenvoorde, R. Buytenhek, C. Blonk, L. B. Tijburg, J. A. Langius, A. E. Meinders, and H. Pijl. 1998. No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arteriosclerosis, Thrombosis, and Vascular Biology 18 (5):833–41. doi: 10.1161/01.atv.18.5.833.
   PubMed Web of Science ®Google Scholar
• Sarma, D. N., M. L. Barrett, M. L. Chavez, P. Gardiner, R. Ko, G. B. Mahady, R. J. Marles, L. S. Pellicore, G. I. Giancaspro, T. Low Dog, et al. 2008. Safety of green tea extracts. Drug Safety 31 (6):469–84. doi: 10.2165/00002018-200831060-00003.
   PubMed Web of Science ®Google Scholar
• Sheikhbahaei, S., T. J. Trahan, J. Xiao, M. Taghipour, E. Mena, R. M. Connolly, and R. M. Subramaniam. 2016. FDG-PET/CT and MRI for evaluation of pathologic response to neoadjuvant chemotherapy in patients with breast cancer: A meta-analysis of diagnostic accuracy studies. The Oncologist 21 (8):931–9. doi: 10.1634/theoncologist.2015-0353.
   PubMed Web of Science ®Google Scholar
• Stroup, D. F., J. A. Berlin, S. C. Morton, I. Olkin, G. D. Williamson, D. Rennie, D. Moher, B. J. Becker, T. A. Sipe, S. B. Thacker, et al. 2000. Meta-analysis of observational studies in epidemiology: A proposal for reporting. JAMA 283 (15):2008–12. doi: 10.1001/jama.283.15.2008.
   PubMed Web of Science ®Google Scholar
• Tabatabaee, S. M., S. M. Alavian, L. Ghalichi, S. M. Miryounesi, K. Mousavizadeh, S. Jazayeri, and M. R. Vafa. 2017. Green tea in non-alcoholic fatty liver disease: A double blind randomized clinical trial. Hepatitis Monthly 17 (12) doi: 10.5812/hepatmon.14993.
   Web of Science ®Google Scholar
• Ui, A., S. Kuriyama, M. Kakizaki, T. Sone, N. Nakaya, K. Ohmori-Matsuda, A. Hozawa, Y. Nishino, and I. Tsuji. 2009. Green tea consumption and the risk of liver cancer in Japan: The Ohsaki Cohort study. Cancer Causes & Control 20 (10):1939–45. doi: 10.1007/s10552-009-9388-x.
   PubMed Web of Science ®Google Scholar
• Unno, T., K. Kondo, H. Itakura, and T. Takeo. 1996. Analysis of (-)-epigallocatechin gallate in human serum obtained after ingesting green tea. Bioscience, Biotechnology, and Biochemistry 60 (12):2066–8. doi: 10.1271/bbb.60.2066.
   PubMed Web of Science ®Google Scholar
• Writing Group Members, Véronique, L. R., A. S. Go, D. M. Lloyd-Jones, E. J. Benjamin, J. D. Berry, W. B. Borden et al. 2012. Heart disease and stroke statistics—2012 update: A report from the American Heart Association. Circulation 125 (1):e2.
   PubMed Web of Science ®Google Scholar
• Yusuf, S., S. Hawken, S. Ôunpuu, T. Dans, A. Avezum, F. Lanas, M. McQueen, A. Budaj, P. Pais, J. Varigos, et al. 2004. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. The Lancet 364 (9438):937–52. doi: 10.1016/S0140-6736(04)17018-9.
   PubMed Web of Science ®Google Scholar